Get In Touch
Xeraya Capital Sdn Bhd
26.03–26.08, G Tower
#199 Jalan Tun Razak, KL
xeraya@xeraya.com
+603 2381 8700
Submit a Proposal
proposal@xeraya.com
Back

News & Events

Latest news and events related to our activities and our portfolio partners.
  • Xeraya Admin
  • Posted by Xeraya Admin
February 24, 2020
24 min read

The Edge Cover Story: The Appeal of Life Sciences

  • Xeraya Admin
  • Posted by Xeraya Admin
February 6, 2020
4 min read

Aria CV Receives FDA Breakthrough Designation for Its Medical Device for Treating Pulmonary Arterial Hypertension

  • Xeraya Admin
  • Posted by Xeraya Admin
February 5, 2020
2 min read

InterVenn innovates cancer diagnostics using AI

  • Xeraya Admin
  • Posted by Xeraya Admin
February 4, 2020
4 min read

Khazanah-backed Xeraya Capital seeks $400m for fourth life sciences fund

  • Xeraya Admin
  • Posted by Xeraya Admin
January 27, 2020
4 min read

Liquidia Submits New Drug Application for LIQ861 (treprostinil) inhalation powder to U.S. Food and Drug Administration for the Treatment of Pulmonary Arterial Hypertension (PAH)

  • Xeraya Admin
  • Posted by Xeraya Admin
January 13, 2020
3 min read

Imago Receives Fast Track Designation from U.S. FDA for Bomedemstat for Treatment of Essential Thrombocythemia

  • Xeraya Admin
  • Posted by Xeraya Admin
December 2, 2019
2 min read

ViewRay Announces Collaborations with Elekta and Medtronic

  • Xeraya Admin
  • Posted by Xeraya Admin
November 12, 2019
3 min read

ViewRay Reports Third Quarter 2019 Results

  • Xeraya Admin
  • Posted by Xeraya Admin
October 15, 2019
2 min read

ViewRay Announces Preliminary Third Quarter 2019 Results and Details of Upcoming Conference Call

  • Xeraya Admin
  • Posted by Xeraya Admin
October 8, 2019
5 min read

Acutus Medical and Innovative Health, Inc. Collaborate to Increase Patient Access to Best-in-Class Electrophysiology Care

  • Xeraya Admin
  • Posted by Xeraya Admin
October 7, 2019
5 min read

Joint Cancer Program in Boston First in New England to Offer MRI-Guided Radiation Therapy

  • Xeraya Admin
  • Posted by Xeraya Admin
October 1, 2019
3 min read

Conformis and Stryker Execute Development, License and Distribution Agreements

  • Xeraya Admin
  • Posted by Xeraya Admin
August 22, 2019
3 min read

Iconic Therapeutics Signs Ophthalmology Option Agreement

  • Xeraya Admin
  • Posted by Xeraya Admin
August 16, 2019
1 min read

Passing away of Xeraya’s Board Member, Allahyarham Dr. Zainul Fadziruddin

  • Xeraya Admin
  • Posted by Xeraya Admin
August 6, 2019
4 min read

Novo Holdings Invests $72 Million in Sustainable Products Leader LanzaTech

  • Xeraya Admin
  • Posted by Xeraya Admin
July 31, 2019
3 min read

Nephron And Rapid Micro Biosystems Partner On Automated Microbial Monitoring Innovation

  • Xeraya Admin
  • Posted by Xeraya Admin
July 10, 2019
4 min read

Acutus Medical Announces Addition of Scott Huennekens as Executive Chairman of the Board

  • Xeraya Admin
  • Posted by Xeraya Admin
June 20, 2019
5 min read

Acutus Medical Announces $170 Million Financing

  • Xeraya Admin
  • Posted by Xeraya Admin
June 17, 2019
4 min read

MLSCF II Inscripta to Present First Data From Its Digital Genome Engineering Technology at Upcoming Synthetic Biology Conference

  • Xeraya Admin
  • Posted by Xeraya Admin
June 6, 2019
4 min read

OncoMyx Therapeutics Completes $25 Million Series A Financing

  • Xeraya Admin
  • Posted by Xeraya Admin
May 23, 2019
4 min read

Xeraya Capital joins the Series B financing of Imago Biosciences

  • Xeraya Admin
  • Posted by Xeraya Admin
May 22, 2019
4 min read

World's First MRIdian Center Treats 1,000th Patient with MRI-Guided Radiation Therapy

  • Xeraya Admin
  • Posted by Xeraya Admin
May 9, 2019
4 min read

Acutus Medical Expands AFib Offerings; Announces Strategic Acquisition and New Partnerships in Monitoring and Therapy

  • Xeraya Admin
  • Posted by Xeraya Admin
April 26, 2019
4 min read

Acutus Medical's New Contact Mapping Software Receives CE Mark